Table of Contents
DEERFIELD, Ill. – Walgreens Specialty Pharmacy has achieved full accreditation from URAC for its Specialty Pharmacy Accreditation 5.0 program and additional accreditation from the Accreditation Commission for Health Care (ACHC) for select community-based Walgreens Specialty Pharmacy locations. These accreditations highlight Walgreens’ dedication to maintaining the highest patient care and safety standards.
URAC, a leading independent healthcare accrediting body, awarded Walgreens full accredited status in its Specialty Pharmacy, Version 5.0 Program. Meanwhile, ACHC, a globally recognized accrediting organization, granted additional Walgreens Specialty Pharmacy community locations the ACHC Specialty Pharmacy Accreditation.
“At Walgreens Specialty Pharmacy, we’re proud to continue our relationship with both URAC and ACHC to better serve our patients,” said Tracey James, RPh, chief operating officer, Walgreens Specialty Pharmacy. “These accreditations are a testament to our commitment to providing our Specialty Pharmacy patients with safe and compliant care.”
The URAC accreditation is effective from February 1, 2025, to January 1, 2028, while the ACHC accreditation is valid from December 17, 2024, to June 28, 2027.
Walgreens Specialty Pharmacy provides services to 300 million covered lives nationwide, offering expert care for patients managing rare and chronic diseases such as cancer, cystic fibrosis, and Crohn’s disease. With specialized training, Walgreens’ pharmacists ensure the safe handling, administration, and monitoring of specialty medications while assisting patients in navigating affordability and adherence challenges.
